Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event.
Bacterial Capsules
Child
Child, Preschool
Diphtheria-Tetanus-acellular Pertussis Vaccines
/ administration & dosage
Drug-Related Side Effects and Adverse Reactions
/ etiology
Haemophilus Vaccines
/ administration & dosage
Humans
Immunization Schedule
Infant
Models, Theoretical
Pneumococcal Vaccines
/ administration & dosage
Risk
Journal
Drug safety
ISSN: 1179-1942
Titre abrégé: Drug Saf
Pays: New Zealand
ID NLM: 9002928
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
3
7
2020
medline:
24
8
2021
entrez:
3
7
2020
Statut:
ppublish
Résumé
Childhood immunization schedules often involve multiple vaccinations per visit. When increased risk of an adverse event is observed after simultaneous (same-day) vaccinations, it can be difficult to ascertain which triggered the adverse event. This methods paper discusses a systematic process to determine which of the simultaneously administered vaccine(s) are most likely to have caused an observed increase in risk of an adverse event. We use an example from the literature where excess risk of seizure was observed 1 day after vaccination, but same-day vaccination patterns made it difficult to discern which vaccine(s) may trigger the adverse event. We illustrate the systematic identification process using a simulation that retained the observed pattern of simultaneous vaccination in an empirical cohort of vaccinated children. We simulated "true" effects for diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) on risk of seizure the day after vaccination. We varied the independent and interactive effects of vaccines (on the multiplicative scale). After applying the process to simulated data, we evaluated risk of seizure 1 day after vaccination in the empirical cohort. In all simulations, we were able to determine which vaccines contributed to excess risk. In the empirical data, we narrowed the association with seizure from all vaccines in the schedule to three likely candidates, DTaP, PCV, and/or Haemophilus influenzae type B (HiB) (p < 0.01, attributable risk when all three were administered together: five per 100,000). Disentangling their associations with seizure would require a larger sample or more variation in the combinations administered. When none of these three were administered, no excess risk was observed. The process outlined could provide valuable information on the magnitude of potential risk from individual and simultaneousvaccinations. Associations should be further investigated with independent data as well as biologically based, statistically independent hypotheses.
Identifiants
pubmed: 32613596
doi: 10.1007/s40264-020-00967-8
pii: 10.1007/s40264-020-00967-8
pmc: PMC7501163
mid: NIHMS1608870
doi:
Substances chimiques
Diphtheria-Tetanus-acellular Pertussis Vaccines
0
Haemophilus Vaccines
0
Haemophilus influenzae type b polysaccharide vaccine
0
Pneumococcal Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1057-1065Subventions
Organisme : NIAID NIH HHS
ID : R01 AI107721
Pays : United States
Références
Vaccine. 2014 Sep 22;32(42):5390-8
pubmed: 25108215
Vaccine. 2009 Aug 27;27(39):5307-12
pubmed: 19616500
Pediatr Infect Dis J. 2014 Jan;33(1):73-80
pubmed: 24346596
Vaccine. 2006 May 15;24(20):4321-7
pubmed: 16581162
Pediatrics. 2016 Jul;138(1):
pubmed: 27273711
Vaccine. 2016 Jun 8;34(27):3030-3036
pubmed: 27160040
Pediatr Infect Dis J. 2004 Mar;23(3):240-5
pubmed: 15014300
JAMA. 2012 Feb 22;307(8):823-31
pubmed: 22357833
Hum Vaccin Immunother. 2013 Aug;9(8):1691-7
pubmed: 23744509
Pharmacoepidemiol Drug Saf. 2010 May;19(5):529-32
pubmed: 20309840
Int J Epidemiol. 1981 Dec;10(4):383-7
pubmed: 7327838
Am J Epidemiol. 1980 Oct;112(4):467-70
pubmed: 7424895
Pediatrics. 2015 Oct;136(4):e848-55
pubmed: 26371192